By Benjamin Chiou
Date: Tuesday 30 Jul 2024
LONDON (ShareCast) - (Sharecast News) - Procter & Gamble's stock took a hit on Tuesday after the American consumer goods giant underwhelmed investors with its quarterly sales figures.
P&G's fourth-quarter earnings came in better than expected, but revenues missed the mark by some $200m, causing shares to tank 5.9% to $159.89 by 1017 in New York.
Net sales in the fourth quarter totalled $20.5bn, down from $20.6bn a year earlier and shy of the $20.7bn consensus forecast, with unfavourable FX movements knocking two percentage points off the top line, offsetting improvements in volumes and pricing.
Nevertheless, core earnings per share improved by 2% year-on-year to $1.40, ahead of the $1.37 expected by the market.
Despite the top-line miss, chairman and chief executive Jon Moeller said his company "met or exceeded" targets for organic sales growth, core EPS growth, cash generation and shareholder returns.
For 2024 as a whole, P&G generated $84bn in sales, a 2% increase on 2023, while core EPS rose 12% to $6.59.
"As we look forward to fiscal 2025, we expect to deliver strong organic sales growth, EPS growth and free cash flow productivity - each in-line with our long-term growth algorithm," Moeller said.
P&G expects to grow sales by 2% to 4% in fiscal-year 2025, while FX is expected to have a one percentage point negative impact. Core EPS is projected to rise by 5% to 7%, equating to a range of $6.91 to $7.05.
Email this article to a friend
or share it with one of these popular networks:
| Currency | US Dollars |
| Share Price | $ 143.45 |
| Change Today | $ -1.91 |
| % Change | -1.31 % |
| 52 Week High | $176.26 |
| 52 Week Low | $143.25 |
| Volume | 577 |
| Shares Issued | 2,341.90m |
| Market Cap | $335,946m |
| Beta | 0.18 |
| RiskGrade | 76 |
| Strong Buy | 7 |
| Buy | 9 |
| Neutral | 11 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 27 |

You are here: research